Venture capital fund · 1 deal
Every published round Bioshore took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Vexev | undisclosed | 7 Aug 2026 | $8.6m | Participant | SmartCompany, Startup Daily, This Week in Australian Startups, vexev.com, Ten13 portfolio |
Companies Bioshore has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Vexev | AI-powered robotic ultrasound for vascular imaging | 7 Aug 2026, undisclosed | 1 | 0 |
Fund closes reported for Bioshore, as distinct from the investments it has made.
Companies Bioshore has backed that another company then bought. An exit for the holding, not a deal Bioshore did.
Stories naming Bioshore. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Eight Australian and New Zealand startups secured a combined $67.4 million in funding across various sectors including agtech, medtech, robotics, and fintech.